Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology
Int J Radiat Oncol Biol Phys
.
2020 Oct 1;108(2):483-485.
doi: 10.1016/j.ijrobp.2020.06.056.
Authors
Michael F Gensheimer
1
,
Sue S Yom
2
,
Nancy Soto
3
,
James J Dignam
3
,
Quynh-Thu Le
4
,
Mitchell Machtay
5
,
Walter J Curran
6
Affiliations
1
Stanford University, Stanford, California. Electronic address: mgens@stanford.edu.
2
University of California San Francisco, San Francisco, California.
3
NRG Oncology, Philadelphia, Pennsylvania.
4
Stanford University, Stanford, California.
5
University Hospitals, Cleveland Medical Center, Cleveland, Ohio.
6
Emory University School of Medicine, Atlanta, Georgia.
PMID:
32890539
PMCID:
PMC7462891
DOI:
10.1016/j.ijrobp.2020.06.056
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Pandemics*
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Grants and funding
U10 CA180822/CA/NCI NIH HHS/United States
U10 CA180868/CA/NCI NIH HHS/United States
UG1 CA189867/CA/NCI NIH HHS/United States